PTHS - Chromocell Therapeutics Corp
23
0.050 0.217%
Share volume: 18,667
Last Updated: 04-21-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.21%
PREVIOUS CLOSE
CHG
CHG%
$22.95
0.05
0.00%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-27-2025 | 05-13-2025 | 11-13-2025 | 03-19-2026 | |
| Cash flow financing | -71.196 K | 250.000 K | 26.692 M | 18.019 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 121.000 K | |
| Cash flow | 0.000 | -382.126 K | 14.194 M | 3.770 M | |
| Net income | -1.927 M | -1.968 M | -16.238 M | -21.664 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 340.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 2.761 M | -7.997 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -741.460 K | -382.126 K | 14.194 M | 3.770 M |